|
|
|
HEADLINES
|
|
|
| | Today, Wed, Feb 10, 2010 | [video] Stock Wrap: The Real Story, February 9
- at TheStreet.com Wed 3:22AM | | Tue, Feb 9, 2010 | AstraZeneca Goes to the Well One Last Time
- at Minyanville.com Tue 11:20PM | The New Danger for Foreign Investors?
- at Motley Fool Tue 9:52PM | Five Growth Stocks With a Margin of Safety
- at TheStreet.com Tue 3:30PM | | Mon, Feb 8, 2010 | Teva gets Nordic and Baltic rights for MS drug from Active Biotech
- at bizjournals.com Mon, Feb 8 | Teva, Active extend pact on oral MS therapy
- at MarketWatch Mon, Feb 8 | Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
- Business Wire Mon, Feb 8 | | Sat, Feb 6, 2010 | Teva Settles Lawsuits for $315 Million
- at Fox Business Sat, Feb 6 | [$$] Teva Reaches Preliminary Settlement In Drug Pricing Suit
- at The Wall Street Journal Online Sat, Feb 6 | | Fri, Feb 5, 2010 | Emerging-Market ETFs Still Have Steam
- at TheStreet.com Fri, Feb 5 | The Stocks You Need to Buy Now
- at Motley Fool Fri, Feb 5 | Teva Pharma settles some Medicaid drug price suits
- AP Fri, Feb 5 | UPDATE - Teva reaches settlement in drug pricing lawsuits
- at Reuters Fri, Feb 5 | Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
- Business Wire Fri, Feb 5 | Earnings Growth Proves Drugmaker Made Right Moves
- Investor's Business Daily Fri, Feb 5 | | Thu, Feb 4, 2010 | Three Safe Stocks With Good Yield
- RealMoney by TheStreet.com Thu, Feb 4 | | Wed, Feb 3, 2010 | Teva, Amgen Duke It Out Over Generic Biotech
- at The Wall Street Journal Online Wed, Feb 3 | | Tue, Feb 2, 2010 | UPDATE - FDA to review Teva biosimilar of Amgen's Neupogen
- at Reuters Tue, Feb 2 | Cephalon Enters Generics Market
- Zacks.com Tue, Feb 2 | Teva Announces FDA Accepts BLA for XM02
- Business Wire Tue, Feb 2 |
|
|
|
|
0.18 (0.32%)